OUR INNOVATION

RESEARCH AND DEVELOPMENT

We focus on innovation and quality with our two R&D centres and vertically integrated manufacturing facilities located in Europe, always centered on innovation to deliver solutions for unmet needs.

OUR INNOVATION

The Group, also thanks to the development of new synergies between the two companies, is increasing its intellectual property portfolio, with almost 150 product and 127 design patents registered as of December 31, 2019, always confirming its objective: to stand out for its continuous innovation and willingness to be a pioneer in the diabetes and self-care markets. A strong vocation to innovation allows MTD to maintain a long-lasting history of collaboration and partnerships with leading pharma corporates, as well as innovative start-ups and creative talented professionals, and to jointly develop innovative medical device solutions with current and new partners, by leveraging their capabilities and experiences.
MTD Engineering, an innovation hub with four focus areas, was established in 2020: embryonic concept/pipeline development in-house or in partnership, production of components for third-party devices, finished products for new segments, and market-facing technical and consulting services.

OUR KEY INNOVATIONS

Within Diabetes & Sharps, our innovation efforts focus on bringing to the market new safety lancets, new and thinner pen needles and safety pen needles, as well as shorter lengths across the thin pen needle versions.

OUR KEY INNOVATIONS

Our innovation efforts focused on bringing new, state-of-the-art self-care medical devices engineered on the basis of an exclusive Design Language System, while improving simplicity and comfort of use.

OUR INNOVATION

RESEARCH AND DEVELOPMENT

We focus on innovation and quality with our two R&D centres and vertically integrated manufacturing facilities located in Europe, always centered on innovation to deliver solutions for unmet needs.

OUR INNOVATION

OUR INNOVATION

The Group, also thanks to the development of new synergies between the two companies, is increasing its intellectual property portfolio, with almost 150 product and 127 design patents registered as of December 31, 2019, always confirming its objective: to stand out for its continuous innovation and willingness to be a pioneer in the diabetes and self-care markets. A strong vocation to innovation allows MTD to maintain a long-lasting history of collaboration and partnerships with leading pharma corporates, as well as innovative start-ups and creative talented professionals, and to jointly develop innovative medical device solutions with current and new partners, by leveraging their capabilities and experiences.
MTD Engineering, an innovation hub with four focus areas, was established in 2020: embryonic concept/pipeline development in-house or in partnership, production of components for third-party devices, finished products for new segments, and market-facing technical and consulting services.

OUR KEY INNOVATIONS

Within Diabetes & Sharps, our innovation efforts focus on bringing to the market new safety lancets, new and thinner pen needles and new and thinner safety pen needles, as well as various lengths across the thin pen needle versions.

OUR KEY INNOVATIONS

Our innovation efforts focused on bringing new, state-of-the-art self-care medical devices engineered on the basis of an exclusive Design Language System, while improving simplicity and comfort of use.